|
Real-time Estimate
Cboe BZX
12:09:25 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 37.96 USD | +2.25% |
|
-3.36% | - |
| 08-12 | Avalyn Pharma's Q2 Net Loss Widens | MT |
| 08-12 | Earnings Flash (AVLN) Avalyn Pharma Posts Q2 Net Loss $28.9M, vs. FactSet Est of $28.6M Loss | MT |
| Market Cap | 1.65B 1.41B 1.31B 1.21B 2.27B 158B 2.31B 15.6B 6.08B 78.94B 6.18B 6.05B 261B | P/E 2026 * |
-11.9x | P/E 2027 * | -12.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.66B 1.42B 1.33B 1.22B 2.29B 159B 2.33B 15.76B 6.14B 79.72B 6.24B 6.11B 264B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
100% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Avalyn Pharma Inc.
| 1 day | +1.54% | ||
| 1 week | -3.90% | ||
| Current month | +31.02% | ||
| 1 month | +29.93% | ||
| 3 months | +32.77% |
| 1 week | 36.17 |  | 40.17 |
| 1 month | 26.81 | | 40.17 |
| Current year | 24.15 | | 40.17 |
| 1 year | 24.15 | | 40.17 |
| 3 years | 24.15 | | 40.17 |
| 5 years | 24.15 | | 40.17 |
| 10 years | 24.15 | | 40.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lyn Baranowski
CEO | Chief Executive Officer | 50 | 2022-10-13 |
Douglas Carlson
DFI | Director of Finance/CFO | 47 | 2024-04-30 |
Howard Lazarus
CTO | Chief Tech/Sci/R&D Officer | 60 | 2023-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ketan Patel
BRD | Director/Board Member | 51 | 2017-02-28 |
Tiba Aynechi
BRD | Director/Board Member | 50 | 2017-02-28 |
Lyn Baranowski
BRD | Director/Board Member | 50 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/29/26 | Free | Director | 26,978 | - | ||
| 4/29/26 | Free | Chief Financial Officer | 211,975 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.54% | -3.90% | - | - | 1.65B | |
| -3.00% | +0.33% | +77.39% | +109.41% | 73.96B | |
| +1.97% | +23.50% | +56.56% | +97.72% | 64.66B | |
| +1.33% | +2.30% | -4.53% | +475.41% | 27.32B | |
| +6.98% | +27.51% | +7.15% | +0.99% | 27.86B | |
| +2.74% | +11.55% | +66.56% | +27.34% | 25.97B | |
| +0.47% | +6.12% | +36.66% | -13.79% | 19.98B | |
| +1.82% | -3.11% | +245.72% | +423.83% | 17.84B | |
| +0.94% | +2.38% | +24.83% | +552.12% | 16.24B | |
| +1.46% | +6.34% | +40.76% | +154.98% | 13.3B | |
| Average | +1.56% | +5.69% | +61.23% | +203.11% | 28.88B | |
| Weighted average by Cap. | +0.92% | +6.63% | +60.07% | +161.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -124M -107M -99.41M -91.22M -171M -11.91B -175M -1.18B -460M -5.97B -467M -457M -19.76B | -135M -116M -108M -99.3M -187M -12.96B -190M -1.28B -500M -6.5B -509M -498M -21.51B |
| Net Debt | 16.4M 14.04M 13.1M 12.02M 22.58M 1.57B 23.03M 155M 60.57M 786M 61.57M 60.23M 2.6B | -442M -379M -353M -324M -609M -42.33B -621M -4.19B -1.63B -21.22B -1.66B -1.63B -70.24B |
Employees
55
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | US$37.93 | +2.15% | 40,894 |
| 26-08-20 | US$37.13 | -4.72% | 179,276 |
| 26-08-19 | US$38.97 | +0.28% | 141,729 |
| 26-08-18 | US$38.86 | +1.59% | 194,791 |
| 26-08-17 | US$38.25 | -2.55% | 148,863 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
37.13USD
Average target price
62.25USD
Spread / Average Target
+67.65%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AVLN Stock
Select your edition
All financial news and data tailored to specific country editions
